Increase Prevalence of Pelvic Floor Disorders is expected to Fuel the Growth of the Market of its Pelvic Floor Diagnostic Testing Services Pelvic floor disorders are the significant public health ...
When news breaks, you need to understand what actually matters. At Vox, our mission is to help you make sense of the world — and that work has never been more vital. But we can’t do it on our own. We ...
The American Academy of Family Physicians (AAFP) no longer recommends pelvic examinations in asymptomatic women unless needed for guideline-appropriate cervical cancer screening, according to its ...
Pelvic floor disorders are the significant public health issue irrespective of age or gender. It consists of a group of disorders resulting in pelvic pain and discomfort. Symptoms associated with the ...
Scientists have developed a simple test for endometriosis, a painful pelvic condition that can cause infertility in women. The new test could replace a laparoscopy - a surgical procedure performed ...
A major move toward public safety may be one step closer with the U.S. Food and Drug Administration announcing this week that it will put a proposal out for public comment that would reclassify pelvic ...
A study has found no evidence pelvic exams are effective for catching gynecological diseases. While Pap smears are used to catch cervical cancer, a pelvic test is designed to feel for enlarged organs ...
Amerinet, a national healthcare group purchasing organization, has announced it has signed an agreement with Mediwatch for urodynamics diagnostic equipment and urology/pelvic floor clinical testing ...
AUSTIN, Texas, June 10, 2020 (GLOBE NEWSWIRE) -- Vermillion, Inc. (VRML), a bioanalytical-based women’s health company focused on gynecologic disease, is excited to announce that its wholly-owned ...
‘ROUTINE GYNAECOLOGICAL examinations are bad medicine.” This must sound like music to the ears of women of all ages, who, by and large, dread the invasive aspects of having a cervical smear carried ...
AUSTIN, Texas, June 10, 2020 (GLOBE NEWSWIRE) -- Vermillion, Inc. (Nasdaq: VRML), a bioanalytical-based women’s health company focused on gynecologic disease, is excited to announce that its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results